manag
preschool
wheez
jayesh
bhatt
alan
r
smyth
wheez
defin
continu
highpitch
sound
music
qualiti
emit
chest
expir
wheez
common
symptom
preschool
children
almost
half
children
least
one
episod
wheez
age
year
much
progress
made
classifi
wheez
ill
older
children
categoris
term
stepwis
manag
base
sever
nation
intern
guidelin
preschool
wheez
defin
epidemiolog
studi
accord
natur
histori
symptom
onset
year
may
term
transient
resolv
year
persist
continu
year
late
onset
wheez
refer
symptom
commenc
year
persist
whilst
classif
may
help
understand
mechan
natur
histori
wheez
ill
young
children
help
clinic
manag
pragmat
clinic
classif
therefor
propos
divid
wheez
ill
preschool
children
episod
viral
wheez
multipletrigg
wheez
use
term
review
children
episod
viral
wheez
well
episod
common
viral
trigger
includ
rhinoviru
respiratori
syncyti
viru
rsv
coronaviru
human
metapneumoviru
parainfluenza
viru
adenoviru
paediatr
respiratori
review
educ
aim
reader
becom
familiar
diagnost
label
difficulti
preschool
children
wheez
abl
discuss
manag
preschool
wheez
awar
current
evid
regard
differ
treatment
strategi
preschool
wheez
ruttl
multitrigg
episod
viral
wheez
inhal
corticosteroid
montelukast
u
r
wheez
common
symptom
preschool
children
continu
highpitch
sound
music
qualiti
emit
chest
expir
pragmat
clinic
classif
episod
viral
wheez
multipletrigg
wheez
diagnost
difficulti
includ
condit
give
rise
noisi
breath
could
misinterpret
wheez
preschool
children
wheez
need
rigor
investig
primari
prevent
possibl
avoid
environment
tobacco
smoke
exposur
strongli
encourag
bronchodil
provid
symptomat
relief
acut
wheezi
episod
evid
use
oral
steroid
conflict
children
present
emerg
depart
ed
parent
initi
oral
steroid
cours
recommend
high
dose
inhal
corticosteroid
ic
use
intermitt
effect
children
frequent
episod
moder
sever
episod
viral
wheez
multipletrigg
wheez
associ
short
term
effect
growth
recommend
routin
mainten
treatment
low
moder
continu
ic
pure
episod
viral
wheez
ineffect
whilst
low
moder
dose
regular
ic
work
multitrigg
wheez
medic
modifi
natur
histori
condit
even
success
trial
treatment
ic
break
treatment
given
see
symptom
resolv
continu
therapi
still
requir
mainten
well
intermitt
montelukast
role
episod
multi
trigger
wheez
good
multidisciplinari
support
educ
essenti
manag
common
condit
elsevi
ltd
right
reserv
routin
clinic
practic
microbiolog
diagnost
studi
rare
perform
young
infant
episod
viral
wheez
may
difficult
distinguish
acut
bronchiol
least
definit
use
clinic
syndrom
bronchiol
vari
differ
part
world
uk
australia
part
europ
bronchiol
defin
presenc
upper
respiratori
tract
symptom
coryza
cough
preced
abrupt
onset
lower
respiratori
symptom
variabl
degre
respiratori
distress
feed
difficulti
hypoxia
auscult
widespread
crepit
wheez
may
may
present
north
america
part
europ
term
bronchiol
gener
appli
condit
involv
expiratori
wheez
evid
respiratori
viral
infect
rhinorrhoea
cough
whether
initi
episod
classifi
bronchiol
irrelev
recurr
wheez
common
follow
initi
infect
rsv
virus
case
rsv
studi
show
disappear
age
yr
associ
increas
risk
atopi
rhinoviru
longterm
data
lack
episod
viral
wheez
commonli
declin
time
disappear
age
yr
continu
episod
viral
wheez
school
age
chang
multipletrigg
wheez
disappear
older
age
factor
influenc
frequenc
sever
episod
includ
sever
first
episod
atopi
prematur
exposur
tobacco
smoke
viral
infect
also
one
import
precipit
multipletrigg
wheez
factor
passiv
smoke
exposur
allergen
exercis
also
import
children
multipletrigg
wheez
may
therefor
symptom
confin
discret
episod
interv
symptom
nocturn
cough
exercis
induc
dyspnoea
phenotyp
defin
task
forc
report
exhaust
individu
patient
may
fit
categori
describ
also
overlap
phenotyp
patient
move
one
phenotyp
parent
may
ascrib
differ
mean
word
wheez
understood
health
profession
lead
overdiagnosi
wheez
ill
parent
understand
wheez
often
differ
definit
use
epidemiolog
studi
mani
parent
better
locat
sound
rather
label
seri
interview
parent
first
ask
open
question
ask
would
describ
child
noisi
breath
follow
specif
question
ask
select
medic
terminolog
thought
best
descript
final
ask
select
sound
closest
nois
made
child
number
option
half
parent
use
word
wheez
initi
one
third
still
use
term
end
interview
wherea
use
word
ruttl
doubl
ruttl
also
known
rattl
lower
pitch
rattl
qualiti
lack
music
featur
parent
may
abl
feel
nois
vibrat
babi
back
ruttl
may
relat
excess
secret
abnorm
tone
larger
airway
wheez
ruttl
quit
distinct
acoust
pattern
assess
object
use
acoust
analysi
also
differ
respons
ipratropium
assess
computeris
breath
sound
analysi
clear
reduct
breath
sound
intens
evid
minut
infant
ruttl
minut
wheez
suggest
differ
pathophysiolog
even
amongst
health
profession
inter
observ
variat
assess
wheez
use
stethoscop
furthermor
lung
function
bronchoscop
find
differ
preschool
children
parent
report
wheez
compar
doctor
confirm
wheez
risk
factor
outcom
differ
respiratori
sound
also
differ
children
follow
school
age
view
difficulti
clinician
undertak
detail
clinic
assess
child
place
undu
weight
one
symptom
preval
wheez
ill
preschool
children
uk
seem
increas
silverman
et
al
conduct
repeat
parentcomplet
postal
questionnair
survey
preval
respiratori
symptom
number
preschool
children
report
one
episod
wheez
increas
less
preval
report
us
differ
may
account
use
differ
methodolog
two
studi
silverman
et
al
show
preval
episod
viral
wheez
increas
multipletrigg
wheez
associ
healthcar
cost
care
preschool
children
wheez
ill
uk
estim
million
per
annum
airway
resist
invers
proport
fourth
power
radiu
airway
poiseuil
law
follow
therefor
young
children
smaller
airway
much
like
wheez
preval
wheez
fall
steepli
children
get
older
airway
radiu
increas
young
children
inflammatori
process
caus
airway
oedema
may
narrow
airway
lead
wheez
children
smaller
airway
start
exampl
infant
smoke
mother
vulner
follow
wheez
common
symptom
young
children
wide
differenti
diagnosi
tabl
list
number
differenti
diagnos
appropri
investig
children
characterist
histori
examin
find
keep
episod
viral
wheez
multipletrigg
wheez
need
investig
skin
prick
test
may
identifi
trigger
multipletrigg
wheez
help
allergen
avoid
children
investig
featur
histori
suggest
patholog
list
tabl
saglani
et
al
report
studi
children
sever
recurr
wheez
rigor
investig
includ
bronchoscopi
bronchoalveolar
lavag
bal
endobronchi
biopsi
bal
fluid
analys
eosinophil
lipid
laden
macrophag
subject
bacteri
cultur
seri
children
asthma
base
histolog
appear
bal
eosinophil
diagnos
gastrooesophag
reflux
predomin
infect
intens
investig
justifi
sever
debilit
diseas
find
biopsi
bal
analysi
differ
atop
nonatop
children
multipletrigg
wheez
primari
prevent
asthma
highli
desir
object
practic
reason
attempt
famili
strong
histori
atopi
intervent
may
need
commenc
prenat
intervent
assess
randomis
control
trial
assess
allergen
avoidancemost
commonli
reduc
exposur
hous
dust
mite
intervent
achiev
reduct
hous
dust
mite
allergen
child
immedi
environ
reduct
symptom
wheez
cochran
review
conclud
reduct
exposur
singl
allergen
hous
dust
mite
reduc
preval
physician
diagnos
asthma
five
howev
reduct
exposur
multipl
allergen
earli
life
includ
dietari
inhal
allergen
lead
reduct
preval
doctor
diagnos
asthma
five
around
environment
allergen
reduct
eg
occlus
bed
mattress
expens
dietari
exclus
inconveni
intrus
therefor
intervent
justifi
young
infant
high
risk
asthma
highli
motiv
parent
number
need
treat
per
case
prevent
amongst
mani
reason
encourag
women
contempl
pregnanc
quit
smoke
strong
associ
preschool
wheez
matern
smoke
one
compel
infant
present
acut
episod
wheez
import
distinguish
episod
viral
wheez
bronchiol
diagnost
approach
suggest
tabl
import
make
distinct
bronchodil
produc
best
small
short
live
benefit
given
infant
bronchiol
randomis
control
trial
inhal
bronchodil
preschool
children
wheez
conner
randomis
children
year
receiv
albuterol
salbutamol
placebo
one
week
period
episod
episod
viral
wheez
show
improv
parent
rate
symptom
score
activ
group
kraemer
studi
wheezi
infant
randomis
inhal
albuterol
salbutamol
placebo
measur
pulmonari
function
intervent
significantli
infant
activ
group
show
improv
measur
thorac
ga
volum
airway
conduct
contrast
chavass
et
al
use
cross
design
randomis
wheezi
infant
one
year
salbutamol
placebo
administ
three
time
daili
period
week
found
salbutamol
superior
placebo
term
symptom
control
lung
function
howev
trial
high
attrit
rate
infant
complet
studi
employ
regimen
regular
bronchodil
use
prolong
period
rare
use
clinic
practic
differ
regimen
bronchodil
administr
compar
acut
wheezi
children
cochran
review
camargo
et
al
includ
studi
intermitt
vs
continu
back
back
nebulis
one
restrict
children
studi
enrol
children
age
year
review
find
benefit
continu
nebulis
compar
intermitt
nebulis
wise
advis
caution
extrapol
result
children
especi
young
contrast
cochran
review
bronchodil
administr
spacer
vs
nebulis
includ
trial
involv
children
mani
children
adult
includ
five
trial
preschool
children
children
use
spacer
rather
nebulis
administ
beta
agonist
significantli
reduc
risk
admiss
reduc
length
stay
emerg
depart
spacer
significantli
fewer
advers
effect
tachycardia
effect
ad
anticholinerg
bronchodil
children
studi
cochran
review
includ
trial
includ
children
preschool
age
group
multipl
dose
anticholinerg
bronchodil
ipratropium
bromid
addit
beta
agonist
reduc
admiss
number
need
treat
cochran
review
everard
et
al
studi
effect
ad
anticholinerg
beta
agonist
wheezi
children
two
year
found
combin
group
improv
symptom
score
hour
compar
beta
agonist
alon
short
cours
day
oral
corticosteroid
commonli
administ
wheezi
preschool
children
episod
viral
wheez
multipletrigg
wheez
howev
evid
approach
conflict
cochran
review
includ
children
age
smith
et
al
studi
randomis
control
trial
system
steroid
hospitalis
children
asthma
four
seven
elig
studi
oral
steroid
includ
children
preschool
age
group
review
conclud
use
oral
steroid
may
allow
children
discharg
earli
around
hour
may
lead
shorter
length
stay
random
control
trial
restrict
preschool
age
group
summar
tabl
randomis
control
trial
csonka
et
al
publish
cochran
review
studi
children
age
month
wheez
breath
difficulti
symptom
viral
infect
randomis
children
receiv
prednisolon
mgkgday
day
placebo
prednisolon
group
shorter
hospit
stay
one
day
shorter
shorter
durat
symptom
fewer
children
need
addit
medic
panickar
et
al
studi
almost
preschool
children
randomis
prednisolon
placebo
admiss
hospit
contrast
earlier
studi
found
signific
differ
group
time
children
consid
fit
discharg
time
actual
discharg
differ
seen
two
recent
larg
trial
difficult
explain
panickar
studi
children
enrol
fail
respond
initi
dose
salbutamol
may
sever
group
patient
studi
csonka
half
discharg
emerg
depart
dose
prednisolon
use
csonka
higher
use
panickar
studi
although
latter
studi
per
kilo
dose
vari
age
studi
restrict
children
year
find
also
conflict
daugbjerg
et
al
four
arm
studi
children
age
month
report
significantli
earlier
discharg
group
receiv
prednisolon
vs
terbutalin
alon
contrast
fox
et
al
studi
children
age
month
randomis
trial
found
prednisolon
given
oral
salbutamol
produc
differ
treatment
failur
compar
placebo
plu
salbutamol
parent
children
suffer
episod
viral
wheez
frequent
given
oral
prednisolon
keep
home
administ
first
sign
symptom
effort
truncat
attack
evid
support
practic
evid
consist
neg
effect
singl
dose
oral
prednisolon
mgkg
administ
parent
children
age
year
first
sign
wheez
studi
grant
et
al
doubl
blind
placebo
control
crossov
studi
follow
month
prednisolon
vs
placebo
benefit
prednisolon
term
number
outpati
visit
number
attack
hospitalis
larg
randomis
control
trial
oommen
colleagu
enrol
children
age
year
episod
viral
wheez
advis
parent
administ
studi
medic
prednisolon
placebo
next
episod
studi
medic
administ
day
outcom
mean
day
symptom
score
day
night
time
symptom
children
stratifi
eosinophil
prime
differ
steroid
placebo
group
effect
seen
eosinophil
prime
practic
give
parent
suppli
oral
prednisolon
administ
children
first
sign
wheez
episod
therefor
justifi
recent
survey
physician
parent
suggest
advic
still
commonli
given
doctor
though
alway
recal
parent
episod
viral
wheez
characteris
intermitt
symptom
mani
parent
would
prefer
inhal
corticosteroid
ic
could
given
intermitt
rather
continu
recommend
treatment
asthma
older
individu
cochran
review
ic
treatment
episod
viral
wheez
publish
year
ago
studi
sinc
conduct
tabl
summaris
five
high
qualiti
randomis
control
trial
use
ic
often
high
dose
acut
manag
episod
viral
wheez
preschool
children
studi
list
order
increas
total
daili
dose
given
beclomethason
equival
studi
use
less
rigor
outcom
measur
symptom
score
like
show
benefit
use
outcom
symptom
free
day
older
studi
less
like
mainten
treatment
low
moder
continu
ic
pure
episod
viral
wheez
ineffect
shown
wilson
et
al
compar
budesonid
mcgday
placebo
preschool
children
given
four
month
period
show
signific
differ
overal
score
number
symptom
free
day
acut
episod
symptom
episod
group
situat
multipletrigg
wheez
differ
mainten
ic
role
chavass
et
al
show
improv
mean
daili
symptom
score
symptom
free
day
infant
year
recurr
wheez
treat
fluticason
mcg
twice
daili
via
spacer
compar
placebo
week
infant
person
famili
histori
atopi
pao
et
al
show
airway
resist
measur
interrupt
resist
r
int
improv
bronchodil
respons
reduc
pre
school
children
skin
prick
test
posit
one
inhal
allergen
treat
inhal
fluticason
mcg
twice
daili
via
spacer
week
compar
placebo
mainten
treatment
effect
use
discontinu
episodefre
day
number
exacerb
lung
function
significantli
differ
patient
previous
randomis
fluticason
placebo
stop
treatment
fluticason
around
mcgday
increas
symptom
free
day
whilst
reduc
exacerb
use
reliev
medic
commenc
children
high
asthma
predic
index
around
year
age
howev
studi
fluticason
prevent
lung
function
declin
reduc
airway
reactiv
age
year
furthermor
fluticason
signific
neg
effect
increas
height
achiev
treat
children
around
cm
less
placebo
group
year
trial
standard
dose
ic
trial
therefor
reason
strategi
children
multipletrigg
wheez
therapi
effect
taken
alter
natur
histori
diseas
treatment
continu
success
trial
break
treatment
given
see
symptom
resolv
continu
therapi
still
requir
montelukast
antiinflammatori
medic
leukotrien
receptor
antagonist
ltra
licens
use
children
month
upward
mild
persist
asthma
exercis
induc
symptom
suitabl
formul
granul
avail
preschool
children
summari
product
characterist
list
sleep
disturb
headach
abdomin
pain
diarrhoea
advers
effect
howev
drug
gener
well
toler
long
term
treatment
option
contrast
oral
steroid
therapi
month
multicent
doubleblind
parallelgroup
studi
year
old
children
episod
asthma
exacerb
associ
respiratori
infect
minim
symptom
episod
oral
montelukast
daili
month
compar
placebo
montelukast
reduc
number
exacerb
approxim
compar
placebo
median
time
first
exacerb
reduc
around
month
even
use
shorter
durat
week
montelukast
mg
daili
compar
placebo
produc
clinic
benefit
within
day
start
therapi
children
age
year
signific
improv
daytim
nighttim
symptom
percentag
day
without
symptom
need
bronchodil
oral
corticosteroid
peripher
blood
eosinophil
montelukast
rapid
onset
action
recent
parent
caregiv
initi
intermitt
use
montelukast
therapi
day
symptom
resolv
hour
children
age
year
result
clinic
signific
reduct
symptom
primari
care
visit
emerg
depart
attend
number
day
school
childcar
child
day
lost
work
parent
caregiv
howev
signific
effect
bronchodil
oral
prednisolon
use
intermitt
use
ic
montelukast
shown
benefit
recent
randomis
trial
look
head
head
comparison
intermitt
ic
montelukast
placebo
children
age
month
investig
randomis
children
experienc
least
two
episod
viral
wheez
within
past
year
receiv
either
inhal
budesonid
mg
twice
daili
montelukast
mg
daili
placebo
ic
placebo
ltra
day
signific
effect
therapi
episod
free
day
one
year
period
statist
signific
albeit
modest
reduct
symptom
burden
respiratori
tract
ill
also
children
posit
asthma
predict
index
greater
ill
sever
ie
use
oral
corticosteroid
preced
year
greater
environment
tobacco
smoke
exposur
well
role
primari
prevent
tobacco
smoke
exposur
increas
risk
lower
respiratori
ill
young
children
case
matern
smoke
smoke
amongst
parent
young
children
firmli
discourag
smoke
cessat
intervent
offer
educ
uncontrol
studi
shown
parent
preschool
children
take
part
educ
programm
improv
asthma
knowledg
self
efficaci
rct
use
multipl
teach
session
led
improv
symptom
free
day
child
less
parent
sleep
disturb
accur
administr
asthma
treatment
parent
one
rct
suggest
multisess
educ
session
show
greater
benefit
intervent
use
parent
younger
year
rather
older
preschool
children
year
randomis
studi
development
appropri
educ
target
pre
school
children
rather
parent
led
better
knowledg
complianc
health
howev
anoth
larg
rct
preschool
children
acut
wheez
compar
educ
programm
compris
two
face
face
session
written
inform
written
asthma
action
plan
usual
care
differ
group
subsequ
healthcar
utilis
disabl
score
parent
qualiti
life
parent
knowledg
asthma
assess
month
effect
intervent
appear
prolong
intens
approach
may
impract
routin
clinic
care
effect
manag
preschool
children
episod
viral
wheez
multipletrigg
wheez
requir
care
clinic
assess
rule
altern
diagnosi
clear
discuss
child
parent
like
prognosi
limit
current
treatment
regular
care
reevalu
children
symptom
essenti
wheez
phenotyp
chang
time
preschool
children
high
dose
intermitt
inhal
corticosteroid
mcgday
fluticason
day
low
dose
long
term
mainten
mcg
day
fluticason
associ
reduc
linear
growth
inhal
steroid
use
stop
symptom
improv
treatment
break
employ
montelukast
offer
benefit
episod
viral
wheez
multipletrigg
wheez
parent
initi
cours
oral
steroid
ineffect
whatev
treatment
strategi
chosen
good
multidisciplinari
support
educ
essenti
direct
futur
research
manag
preschool
children
wheez
ongo
epidemiolog
studi
determin
trend
incid
wheez
preschool
children
risk
factor
econom
cost
studi
identifi
marker
steroid
respons
genotyp
phenotyp
biomark
rct
intermitt
montelukast
enrol
entir
preschool
age
group
develop
evalu
improv
drug
deliveri
system
young
children
small
particl
aerosol
next
gener
nebulis
spacer
devic
evalu
improv
support
avoid
admiss
telephon
advic
commun
nurs
support
educ
materi
treatment
action
plan
homeadminist
montelukast
articl
accredit
cme
learn
european
board
accredit
pneumolog
ebap
receiv
cme
credit
success
answer
question
onlin
visit
journal
cme
site
http
wwwprrjournalcom
b
complet
answer
onlin
receiv
final
score
upon
complet
test
c
success
complet
test
may
download
accredit
certif
subject
administr
charg
pleas
answer
true
fals
wheez
continu
highpitch
sound
without
music
qualiti
emit
chest
expir
categori
preschool
wheez
accord
natur
histori
defin
epidemiolog
studi
transient
earli
persist
late
onset
common
viral
trigger
wheez
children
includ
rhinoviru
respiratori
syncyti
viru
rsv
rotaviru
human
metapneumoviru
parainfluenza
viru
adenoviru
parent
may
ascrib
differ
mean
word
wheez
understood
health
profession
mani
parent
better
locat
sound
rather
label
ruttl
rattl
low
pitch
sound
rattl
qualiti
lack
music
featur
requir
bronchodil
treatment
acut
wheezi
episod
improv
parent
rate
symptom
score
measur
lung
function
ad
anticholinerg
bronchodil
beta
agonist
wheezi
children
two
year
benefici
oral
prednisolon
administ
parent
first
sign
wheez
reduc
number
outpati
visit
number
attack
hospitalis
oral
prednisolon
administ
parent
improv
symptom
score
children
eosinophil
prime
incontrovert
evid
oral
steroid
preschool
wheez
children
ineffect
ruttl
distinct
acoust
pattern
compar
wheez
assess
object
use
acoust
analysi
relat
excess
secret
abnorm
tone
larger
airway
atop
nonatop
children
multipletrigg
wheez
differ
find
bronchoalveolar
lavag
bronchial
biopsi
inhal
corticosteroid
preschool
wheez
affect
growth
use
high
dose
intermitt
high
dose
intermitt
inhal
corticosteroid
reduc
oral
steroid
use
preschool
wheez
mainten
treatment
low
moder
continu
ic
improv
symptom
reduc
exacerb
multitrigg
wheez
mainten
inhal
corticosteroid
modifi
natur
histori
pre
school
wheez
success
treatment
trial
inhal
corticosteroid
justifi
continu
therapi
multitrigg
wheez
long
term
regular
use
montelukast
reduc
number
exacerb
prolong
time
next
exacerb
episod
wheez
clinic
benefit
montelukast
seen
within
day
start
treatment
parent
initi
intermitt
use
montelukast
therapi
day
effect
treatment
option
preschool
wheez
intermitt
montelukast
better
high
dose
inhal
corticosteroid
reduc
symptom
burden
episod
wheez
tobacco
smoke
exposur
import
primari
secondari
prevent
preschool
wheez
development
appropri
educ
target
pre
school
children
improv
outcom
knowledg
children
regular
care
reevalu
children
symptom
essenti
wheez
phenotyp
chang
time
preschool
children
